Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Has results × ibrutinib × Clear all

Phase

Phase 2 48 Phase 1/2 24 Phase 3 19 Phase 1 9 Phase 4 1 Phase 2/3 1

Sponsor

Interventions

pembrolizumab 7 Cyclophosphamide 5 durvalumab 3 Vincristine 3 Radiation 3 Metformin 3 Imiquimod 3 Fluorouracil 3 Testosterone 2 Surveys and Questionnaires 2 Rituximab 2 Positron Emission Tomography Computed Tomography 2 Oxaliplatin 2 Leucovorin 2 Lapatinib 2 Immunoglobulin G 2 Doxorubicin 2 Disulfides 2 Cisplatin 2 Biopsy 2 xentuzumab 1 tremelimumab 1 ribociclib 1 posaconazole 1 pexidartinib 1 pazopanib 1 paricalcitol 1 parathyroid hormone-related peptide (1-36) 1 palbociclib 1 oblimersen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡